Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.45 USD | +0.73% | -2.28% | +0.38% |
Sales 2024 * | 1.16B 1.59B | Sales 2025 * | 1.25B 1.71B | Capitalization | 12.2B 16.76B |
---|---|---|---|---|---|
Net income 2024 * | 180M 247M | Net income 2025 * | 228M 313M | EV / Sales 2024 * | 10.7 x |
Net Debt 2024 * | 166M 228M | Net cash position 2025 * | 85.4M 117M | EV / Sales 2025 * | 9.71 x |
P/E ratio 2024 * |
69.2
x | P/E ratio 2025 * |
55.3
x | Employees | 3,050 |
Yield 2024 * |
0.41% | Yield 2025 * |
0.41% | Free-Float | 99.03% |
Latest transcript on Bio-Techne Corporation
1 day | +0.73% | ||
1 week | -2.28% | ||
Current month | +0.34% | ||
1 month | -4.28% | ||
3 months | +4.49% | ||
6 months | +11.92% | ||
Current year | +0.38% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 57 | 18-04-29 |
James Hippel
DFI | Director of Finance/CFO | 53 | 14-03-31 |
Matthew McManus
COO | Chief Operating Officer | 55 | 01-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 02-12-31 | |
Randolph Steer
BRD | Director/Board Member | 74 | 89-12-31 |
Joseph Keegan
BRD | Director/Board Member | 71 | 17-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.93% | 1 M€ | +0.84% | - | |
2.50% | 5 M€ | -1.80% | - | |
2.15% | 2 M€ | -.--% | ||
1.25% | 0 M€ | 0.00% | - | |
1.13% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 77.45 | +0.73% | 782,456 |
24-06-11 | 76.89 | -0.27% | 827,522 |
24-06-10 | 77.1 | -0.68% | 722,231 |
24-06-07 | 77.63 | -1.52% | 897,308 |
24-06-06 | 78.83 | -0.54% | 785,617 |
Delayed Quote Nasdaq, June 12, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.38% | 12.2B | |
+48.54% | 56.61B | |
+36.95% | 39.25B | |
-6.02% | 39.62B | |
-6.90% | 28.28B | |
+12.97% | 26.44B | |
-16.91% | 20.12B | |
+31.71% | 12.48B | |
+28.18% | 12.51B | |
-9.54% | 11.02B |
- Stock Market
- Equities
- TECH Stock